Tommy G. Thompson - 16 Mar 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
16 Mar 2022
Net transactions value
-$407,457
Form type
4
Filing time
18 Mar 2022, 16:36:48 UTC
Previous filing
16 Mar 2022
Next filing
30 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $72,165 +1,500 +23% $48.11 8,020 16 Mar 2022 Direct F1
transaction UTHR Common Stock Disposed to Issuer $273,825 -1,500 -19% $182.55 6,520 16 Mar 2022 Direct F1
transaction UTHR Common Stock Options Exercise $72,598 +1,509 +23% $48.11 8,029 17 Mar 2022 Direct F1
transaction UTHR Common Stock Disposed to Issuer $278,395 -1,509 -19% $184.49 6,520 17 Mar 2022 Direct F1
holding UTHR Common Stock 5,800 16 Mar 2022 Family LLC
holding UTHR Common Stock 8,200 16 Mar 2022 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -1,500 -22% $0.000000 5,209 16 Mar 2022 Common Stock 1,500 $48.11 Direct F2
transaction UTHR Share Tracking Award Options Exercise $0 -1,509 -29% $0.000000 3,700 17 Mar 2022 Common Stock 1,509 $48.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.